药物对比
Troglitazone vs Lixisenatide
Troglitazone（因肝毒性撤市的噻唑烷二酮类）与Lixisenatide（GLP-1激动剂）。比较安全性、用途，以及为什么一种已被淘汰。
此页面暂无可用的对比维度。
临床背景
Triggered by patients reviewing discontinued diabetes drugs against current GLP-1 options like those in Soliqua.
结论
Lixisenatide is the only viable choice since Troglitazone was withdrawn for safety reasons.
全部药物对比